Search
for
Sort by
Research 271–300 of 416
- Spironolacton in dermatologischen Behandlungen
- A recently characterized, underdiagnosed cause of female androgenetic alopecia and polycystic ovarian syndrome: non-classical 21 hydroxylase deficiency
- Risk factors for androgenetic alopecia: a systematic review and meta-analysis
- Improvement of female pattern hair loss with bicalutamide: a time-dependent process
- Glucocorticoid Resistance Syndrome in 2 Patients With Diverse Genotype
- Solubilizing steroidal drugs by β-cyclodextrin derivatives
- Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance
- Megestrol Acetate Increases the Proliferation, Migration, and Adipogenic Differentiation of Adipose-Derived Stem Cells via Glucocorticoid Receptor
- Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care
- Association of Hypertension and Serum Aldosterone Levels in Male Patients with Androgenetic Alopecia: A Case-Control Study
- Green and Emerging Microextraction Strategies for Bioanalytical Determination of Hormones: Trends, Challenges, and Applications
- Spironolactone
- MON-330 Cushing Syndrome Secondary to Neuroendocrine Lung Carcinoma: To X-Ray or Not to X-Ray?
- Corticosterone enhances the potency of ethanol against hippocampal long-term potentiation via local neurosteroid synthesis
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- Treatment options for polycystic ovary syndrome
- Non-Contraceptive Benefits of Oral Hormonal Contraceptives
- Nanocrystals for Improved Drug Delivery of Dexamethasone in Skin Investigated by EPR Spectroscopy
- Metabolic syndrome in androgenic alopecia
- Clinical profile of androgenic alopecia and its association with cardiovascular risk factors
- The effect of hormones of the hypothalamic-pituitary-target gland axes in a kidney-yang deficiency syndrome model
- Androgenetic alopecia as an early marker for hypertension
- Ashwagandha root in the treatment of non-classical adrenal hyperplasia
- Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization